We are building a new company to transform the cell therapy space by developing autologous cell therapies for patients with solid tumors. We are building a company culture based on collaboration, transparency, integrity, and commitment to excellence. We are looking for passionate people to be a part of this journey.
Location: Canada, Ontario, Toronto
Employees: 11-50
Total raised: $10M
Founded date: 2022
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.04.2023 | Seed | $10M | General Ca... |
Mentions in press and media 3
| Date | Title | Description |
| 26.04.2023 | CTRL Therapeutics Raises $10M in Seed Financing | CTRL Therapeutics, a Chicago, IL-based biotechnology company developing a cell therapy platform for solid tumors, raised $10M in Seed funding. The round was led by General Catalyst with participation from Intermountain Health, FACIT and oth... |
| 10.04.2023 | CTRL Therapeutics Launches with $10M Seed Financing | CHICAGO,IL,CTRL Therapeutics announced a $10M seed financing. >> Click here for more funding data on CTRL Therapeutics >> To export CTRL Therapeutics funding data to PDF and Excel, click here CTRL Therapeutics, a biotechn... |
| - | CTRL Therapeutics | “CTRL Therapeutics is leading the new wave of biotechnology, unleashing the power of cell therapy for solid tumors in the fight to find treatments for all cancers.” |